Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover
Harvard Bioscience, Inc. (HBIO) had Days Sales in Receivables of 52.93 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$20.59M |
|
$-1.23M |
|
$8.57M |
|
$12.02M |
|
$20.39M |
|
$0.20M |
|
$-1.33M |
|
$-1.13M |
|
$-1.13M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$-1.23M |
|
$0.20M |
|
$1.88M |
|
44.56M |
|
44.56M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$43.80M |
|
$4.99M |
|
$34.19M |
|
$77.99M |
|
$54.40M |
|
-- |
|
$9.53M |
|
$63.92M |
|
$14.07M |
|
$-3.84M |
|
$14.07M |
|
44.58M |
|
| Cash Flow Statement Financials | |
$6.83M |
|
$-1.26M |
|
$-3.74M |
|
$4.11M |
|
$6.82M |
|
$2.71M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.81 |
|
-- |
|
-- |
|
-- |
|
2.41 |
|
58.38% |
|
0.96% |
|
0.96% |
|
-- |
|
-5.51% |
|
-5.98% |
|
$6.02M |
|
-- |
|
-- |
|
-- |
|
0.26 |
|
0.40 |
|
1.70 |
|
|
Days Sales in Receivables |
52.93 |
-8.75% |
|
32.09% |
|
-1.58% |
|
-8.75% |
|
$0.32 |
|
$0.14 |
|
$0.15 |
|